9167 Outcomes with erlotinib in advanced NSCLC: examining the influence of increased EGFR gene copy number and EGFR mutations

D. Soulières, T. Ciuleanu, L. Stelmakh, R. Whittom, P. Delmar, K. Rohr, W. Brugger, F. Cappuzzo
  • European Journal of Cancer Supplements, September 2009, Elsevier
  • DOI: 10.1016/s1359-6349(09)71880-4

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Federico Cappuzzo